In a recent study, treatment of primary ovarian cancer cells, harvested from ascites of an ovarian cancer patient, simultaneously using CD44-CAR-NK cells and cisplatin led to increased anti-tumor cytotoxicity, compared with monotherapies alone (134). The gene discussed is CD44; the disease is ovarian carcinoma.